and you’re going to get your products either approved or not approved, but it’s going to be a quick process. Surely the pharma execs were thrilled to hear of this, just as American patients will be thrilled to know that more beneficial drugs could soon be flowing through the regulatory pipeline. 5) More drug production ought to be inside the United States.   